West Pharmaceutical Services (WST) valuation history
Historically high
As of
WST's EV/EBITDA of 32.3x is higher than 99% of its available weekly readings from the last five years.
Compared with readings since .
Share EV/EBITDA history
Chart by stockresearch.app. Reuse with credit under CC BY 4.0.
EV/EBITDA at year-end
Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.
| Reading date | EV/EBITDA | 5-year rank |
|---|---|---|
| 26.1× | 86% | |
| Unavailable | Short history | |
| Unavailable | Short history | |
| Unavailable | Short history | |
| Unavailable | Short history | |
| Unavailable | Short history | |
| Unavailable | Short history | |
| Unavailable | Short history | |
| Unavailable | Short history | |
| Unavailable | Short history |
Loading related research…
About this history
- What is WST's current EV/EBITDA?
- WST's EV/EBITDA of 32.3x is higher than 99% of its available weekly readings from the last five years.
- What is WST's five-year median EV/EBITDA?
- The median, or middle weekly reading, is 25.1× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.